Masanori Yasuda

Immunohistochemical and molecular analysis of an α-fetoprotein-producing cervical adenocarcinoma with clear cell morphology

K. Nasu, M. Yano, H. Nishida, 2022, Medical Molecular Morphology.

Prognostic significance of tumor infiltrating lymphocytes on first-line pembrolizumab efficacy in advanced non-small cell lung cancer

Kunihiko Kobayashi, T. Kawasaki, K. Kaira, 2023, Discover Oncology.

PTEN-induced kinase 1 gene single-nucleotide variants as biomarkers in adjuvant chemotherapy for colorectal cancer

Y. Hirano, S. Ryozawa, T. Hamaguchi, 2022, bioRxiv.

Comparison of Fork‐tip and Franseen needles for endoscopic ultrasound‐guided fine‐needle biopsy in pancreatic solid lesions: A propensity‐matched analysis

A. Fujita, S. Ryozawa, M. Mizuide, 2022, DEN open.

Co-clinical study of [fam-] trastuzumab deruxtecan (DS8201a) in patient-derived xenograft models of uterine carcinosarcoma and its association with clinical efficacy.

K. Yonemori, K. Hasegawa, A. Hamada, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment

R. Nishikawa, S. Nobusawa, Tomonari Suzuki, 2023, Brain Tumor Pathology.

Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma

M. Yano, T. Katoh, M. Miwa, 2023, Journal of Ovarian Research.

Identification of novel oncogenes in oral cancer among elderly nonsmokers.

M. Nakahira, M. Sugasawa, Y. Nakachi, 2023, Clinical and experimental dental research.

Prediction Formula for Pathological Depth of Invasion From Clinical Depth of Invasion in Tongue Squamous Cell Carcinoma (SCC) Stage I/II Cases

Satoko Matsumura, M. Nakahira, M. Sugasawa, 2023, Cureus.

Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinib.

Kunihiko Kobayashi, T. Kawasaki, K. Kaira, 2023, Thoracic cancer.

Vimentin‐positive invasive breast carcinoma of no special type: A breast carcinoma with lethal biological characteristics

T. Hasebe, Y. Ichinose, T. Saeki, 2023, Pathology international.